Searched for
PHARMEASY THYROCARE DEAL
Thyrocare to buy home ECG service provider Think HealthDiagnostic provider Thyrocare, backed by Pharmeasy, will acquire a 100% stake in Chennai's Think Health Diagnostics to venture into providi...- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
- PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
- Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parentThe money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare las...
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
- PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
- PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...
- PharmEasy parent API Holdings strengthens board ahead of IPOAPI Holdings — the parent company of PharmEasy — has appointed five independent directors to its board. India's biggest online pharmacy is ...
- PharmEasy plans to file IPO papers by OctoberPharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation ...
- PharmEasy co-founder Siddharth Shah buys Rs 40-crore apartment in Mumbai's KharSiddharth Shah, an IIM-Ahmedabad graduate is chief executive of API Holdings that runs PharmEasy, which was in the news recently after it a...
- Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
- It was the right time and right way to exit, Thyrocare's A Velumani saysArokiaswamy Velumani, who quit a government job at the Bhabha Atomic Research Centre to start Thyrocare in 1995, on why he decided to sell ...
- Entry of big firms in healthcare space will benefit users: PharmEasy's Siddharth ShahAPI Holdings' Siddharth Shah on what’s next for Thyrocare after the PharmEasy deal, API’s existing online drug delivery business, and what ...
- Market Movers: Thyrocare tanks on undercooked open offer; oil stocks rallyAPI Holdings, the owner of PharmEasy, will make an open offer to acquire 26 per cent additional stake in the company after buying out the p...
- Metal stocks unlikely to continue up move: Sandip Sabharwal“The risk reward right now is not in favour. People need to buy at lower prices to make any sort of decent returns.”
- PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- PharmEasy’s $300M booster shotIn today’s ETtech Morning Dispatch: Ant Group may face India curbs after IPOs of Zomato and Paytm, Twitter’s troubles in India continue, Co...
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
- PharmEasy to acquire ThyrocareFrom Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...
Load More
